- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech High ROE Growth Engines
Hong Kong Pharmaceuticals & Biotech High ROE Growth Engines
Results
2
0 new
2 companies
3SBio
Market Cap: HK$43.1b
An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.
1530
HK$17.07
7D
-0.6%
1Y
-46.5%
HBM Holdings
Market Cap: HK$10.9b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$12.62
7D
7.4%
1Y
31.5%